Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nucana Plc ADR (NQ: NCNA ) 2.745 -0.005 (-0.18%) Streaming Delayed Price Updated: 10:10 AM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nucana Plc ADR < Previous 1 2 3 4 5 6 7 Next > Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket September 26, 2024 Via Benzinga NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States September 25, 2024 From NuCana plc Via GlobeNewswire Crude Oil Surges Over 1%; Instil Bio Shares Plunge September 16, 2024 Via Benzinga Exposures Fossil Fuels Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September September 16, 2024 Via Benzinga Topics Stocks Exposures US Equities NCNA Stock Earnings: NuCana Beats EPS for Q2 2024 August 15, 2024 NCNA stock results show that NuCana beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace NCNA Stock Earnings: NuCana Beats EPS for Q1 2024 May 16, 2024 NCNA stock results show that NuCana beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges September 16, 2024 NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% disease control rate in metastatic melanoma patients resistant to prior PD-1... Via Benzinga Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket September 16, 2024 Via Benzinga NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 September 14, 2024 Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile From NuCana plc Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session September 02, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session September 02, 2024 Via Benzinga NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data August 30, 2024 NuCana will discontinue the NuTide:323 study after an initial analysis recommended by the Steering Committee, as the combination treatment was unlikely to achieve superior Progression-Free Survival... Via Benzinga NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study August 29, 2024 From NuCana plc Via GlobeNewswire Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket August 20, 2024 Via Benzinga NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update August 15, 2024 From NuCana plc Via GlobeNewswire NuCana to Present at the Jefferies Global Healthcare Conference May 30, 2024 From NuCana plc Via GlobeNewswire NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit May 21, 2024 From NuCana plc Via GlobeNewswire NuCana Reports First Quarter 2024 Financial Results and Provides Business Update May 16, 2024 From NuCana plc Via GlobeNewswire NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement May 01, 2024 From NuCana plc Via GlobeNewswire NuCana Announces Completion of ADS Ratio Change April 16, 2024 From NuCana plc Via GlobeNewswire NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study April 09, 2024 From NuCana plc Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session April 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 29, 2024 Via Benzinga Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 28, 2024 Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session March 28, 2024 Via Benzinga Why NuCana (NCNA) Shares Are Trading Lower March 28, 2024 NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs). Via Benzinga Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket March 28, 2024 Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 28, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday March 28, 2024 Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning! Via InvestorPlace NuCana Announces Plan to Implement ADS Ratio Change March 27, 2024 From NuCana plc Via GlobeNewswire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.